CD4 and HIV-1 infection: In summary, we identified a turning point when ART was initiated after 2007, coinciding with changes in various parameters, including the size of the HIV-1 reservoir and some surrogate markers of subsequent treatment guidelines (e.g., nadir CD4 or time from diagnosis of HIV-1 infection to initiation of ART).